Occult Hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern Ethiopia

Sci Rep. 2020 Dec 17;10(1):22182. doi: 10.1038/s41598-020-79392-x.

Abstract

The absence of hepatitis B surface antigen (HBsAg) and the presence of antibody to hepatitis B core antigen (anti-HBc) in the blood of apparently healthy individuals may not indicate the absence of circulating hepatitis B virus (HBV) and might be infectious. Despite the risk of HBV transmission, there has been no report from Ethiopia examining this issue; therefore, this study determined occult HBV infection (OBI) among isolated anti-HBc (IAHBc) HIV negative and HIV positive individuals on ART in eastern Ethiopia. A total of 306 IAHBc individuals were included in this study. DNA was extracted, amplified, and detected from plasma using a commercially available RealTime PCR platform (Abbott m2000rt) following the manufacturer's instructions. Data were entered into EPI Data version 3.1, cleaned, and analyzed using Stata version 13. Descriptive analysis was used to calculate prevalence, summarize sociodemographic data and other factors. From the 306 IAHBc individuals (184 HIV positive and 122 HIV negative) included in the study, 183 (59.8%) were female of which 142 (77.6%) were within the reproductive age group. DNA extraction, amplified and detection was conducted in 224 individuals. The overall OBI prevalence was 5.8% (5.6% in HIV negative and 6% in HIV positive) among the IAHBc individuals. The HBV DNA concentration among the occult hepatitis B individuals was < 200 IU/mL, indicating a true occult. This study reported the burden of OBI, which pauses a significant public health problem due to the high burden of HBV infection in the country. OBI may cause substantial risk of HBV transmission from blood transfusion, organ transplantation as well as vertical transmission as screening is solely dependent on HBsAg testing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • CD4 Lymphocyte Count
  • Coinfection / epidemiology*
  • Coinfection / immunology
  • Ethiopia / epidemiology
  • Female
  • HIV Infections / epidemiology*
  • HIV Infections / immunology
  • HIV Infections / transmission
  • HIV Infections / virology
  • Hepatitis B / epidemiology*
  • Hepatitis B / immunology*
  • Hepatitis B / transmission
  • Hepatitis B / virology
  • Hepatitis B Antibodies / blood
  • Hepatitis B Antibodies / immunology*
  • Hepatitis B Core Antigens / immunology
  • Hepatitis B virus / immunology
  • Humans
  • Male
  • Middle Aged
  • Public Health Surveillance
  • Viral Load
  • Young Adult

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Core Antigens